Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Paediatr Anaesth. 2010 Dec 29;21(3):325–334. doi: 10.1111/j.1460-9592.2010.03484.x

Figure 1.

Figure 1

MAP Bayesian individual predictions compared with patient data for R (+) Ketorolac (left) and S (−) Ketorolac (right) plasma concentrations. Note: Patients 4 and 6 received 0.5 mg/kg; Patients 1, 2, 3, 5,7 and 8 received 1.0 mg/kg See Table 2 for individual pharmacokinetic parameters.